[On the fine structure of sieve tube plastids in monocotyls].

H. Behnke

Die Naturwissenschaften

Abstract:

What problem does this paper attempt to address?

AI-Reinforced Wearable Sensors and Intelligent Point-of-Care Tests

Ghita Yammouri,Abdellatif Ait Lahcen

DOI: https://doi.org/10.3390/jpm14111088

IF: 3.5083

2024-11-02

Journal of Personalized Medicine

Abstract:Artificial intelligence (AI) techniques offer great potential to advance point-of-care testing (POCT) and wearable sensors for personalized medicine applications. This review explores the recent advances and the transformative potential of the use of AI in improving wearables and POCT. The integration of AI significantly contributes to empowering these tools and enables continuous monitoring, real-time analysis, and rapid diagnostics, thus enhancing patient outcomes and healthcare efficiency. Wearable sensors powered by AI models offer tremendous opportunities for precise and non-invasive tracking of physiological conditions that are essential for early disease detection and personalized treatments. AI-empowered POCT facilitates rapid, accurate diagnostics, making these medical testing kits accessible and available even in resource-limited settings. This review discusses the key advances in AI applications for data processing, sensor fusion, and multivariate analytics, highlighting case examples that exhibit their impact in different medical scenarios. In addition, the challenges associated with data privacy, regulatory approvals, and technology integrations into the existing healthcare system have been overviewed. The outlook emphasizes the urgent need for continued innovation in AI-driven health technologies to overcome these challenges and to fully achieve the potential of these techniques to revolutionize personalized medicine.

medicine, general & internal,health care sciences & services
Artificial Intelligence in Point-of-Care Biosensing: Challenges and Opportunities

Connor D. Flynn,Dingran Chang

DOI: https://doi.org/10.3390/diagnostics14111100

IF: 3.6

2024-05-26

Diagnostics

Abstract:The integration of artificial intelligence (AI) into point-of-care (POC) biosensing has the potential to revolutionize diagnostic methodologies by offering rapid, accurate, and accessible health assessment directly at the patient level. This review paper explores the transformative impact of AI technologies on POC biosensing, emphasizing recent computational advancements, ongoing challenges, and future prospects in the field. We provide an overview of core biosensing technologies and their use at the POC, highlighting ongoing issues and challenges that may be solved with AI. We follow with an overview of AI methodologies that can be applied to biosensing, including machine learning algorithms, neural networks, and data processing frameworks that facilitate real-time analytical decision-making. We explore the applications of AI at each stage of the biosensor development process, highlighting the diverse opportunities beyond simple data analysis procedures. We include a thorough analysis of outstanding challenges in the field of AI-assisted biosensing, focusing on the technical and ethical challenges regarding the widespread adoption of these technologies, such as data security, algorithmic bias, and regulatory compliance. Through this review, we aim to emphasize the role of AI in advancing POC biosensing and inform researchers, clinicians, and policymakers about the potential of these technologies in reshaping global healthcare landscapes.

medicine, general & internal
Artificial Intelligence, Physiological Genomics, and Precision Medicine.

Anna Marie Williams,Yong Liu,Kevin R. Regner,Fabrice Jotterand,Pengyuan Liu,Mingyu Liang

DOI: https://doi.org/10.1152/physiolgenomics.00119.2017

2018-01-01

Physiological Genomics

Abstract:Big data are a major driver in the development of precision medicine. Efficient analysis methods are needed to transform big data into clinically-actionable knowledge. To accomplish this, many researchers are turning toward machine learning (ML), an approach of artificial intelligence (AI) that utilizes modern algorithms to give computers the ability to learn. Much of the effort to advance ML for precision medicine has been focused on the development and implementation of algorithms and the generation of ever larger quantities of genomic sequence data and electronic health records. However, relevance and accuracy of the data are as important as quantity of data in the advancement of ML for precision medicine. For common diseases, physiological genomic readouts in disease-applicable tissues may be an effective surrogate to measure the effect of genetic and environmental factors and their interactions that underlie disease development and progression. Disease-applicable tissue may be difficult to obtain, but there are important exceptions such as kidney needle biopsy specimens. As AI continues to advance, new analytical approaches, including those that go beyond data correlation, need to be developed and ethical issues of AI need to be addressed. Physiological genomic readouts in disease-relevant tissues, combined with advanced AI, can be a powerful approach for precision medicine for common diseases.
Evolving Applications of Artificial Intelligence and Machine Learning in Infectious Diseases Testing

Nam K Tran,Samer Albahra,Larissa May,Sarah Waldman,Scott Crabtree,Scott Bainbridge,Hooman Rashidi

DOI: https://doi.org/10.1093/clinchem/hvab239

IF: 12.114

2021-12-30

Clinical Chemistry

Abstract:Abstract Background Artificial intelligence (AI) and machine learning (ML) are poised to transform infectious disease testing. Uniquely, infectious disease testing is technologically diverse spaces in laboratory medicine, where multiple platforms and approaches may be required to support clinical decision-making. Despite advances in laboratory informatics, the vast array of infectious disease data is constrained by human analytical limitations. Machine learning can exploit multiple data streams, including but not limited to laboratory information and overcome human limitations to provide physicians with predictive and actionable results. As a quickly evolving area of computer science, laboratory professionals should become aware of AI/ML applications for infectious disease testing as more platforms are become commercially available. Content In this review we: (a) define both AI/ML, (b) provide an overview of common ML approaches used in laboratory medicine, (c) describe the current AI/ML landscape as it relates infectious disease testing, and (d) discuss the future evolution AI/ML for infectious disease testing in both laboratory and point-of-care applications. Summary The review provides an important educational overview of AI/ML technique in the context of infectious disease testing. This includes supervised ML approaches, which are frequently used in laboratory medicine applications including infectious diseases, such as COVID-19, sepsis, hepatitis, malaria, meningitis, Lyme disease, and tuberculosis. We also apply the concept of “data fusion” describing the future of laboratory testing where multiple data streams are integrated by AI/ML to provide actionable clinical knowledge.

medical laboratory technology
Artificial Intelligence in Medical Diagnosis: Methods, Algorithms and Applications

J. H. Kamdar,J. Jeba Praba,John J. Georrge

DOI: https://doi.org/10.1007/978-3-030-40850-3_2

2020-01-01

Abstract:Artificial intelligence (AI) has evolved rapidly since the late 1980s. Increasing of healthcare datasets and its performance, the past two decades have seen an exponential progress in publications on AI. However, with the advent of increased computational power, availability of AI devices was increased. There are two main devices in AI, machine learning, where structured data (i.e. images, EP and genetic data) are analyzed and natural language processing, where unstructured data are analyzed. Both AI devices have been improved in great detail over the past two decades for its methods, algorithms, and applications. However, various attempts and new methods of AI have been used in recent years and few diseases such as cancer, nervous system disease, cardiovascular disease, liver disease, congenital cataract disease, etc. were potentially analyzed using AI. Now a day an advanced method called deep learning has initiated a boom of AI and great modifications of diagnostic medical imaging systems like endoscopic diagnosis, pathology and dermatology will be expected in the near future. Herein, the authors give a basic technical knowledge about popular methods, algorithms and applications in medical diagnosis which emerged in the past years.
Artificial Intelligence toward Personalized Medicine

DOI: https://doi.org/10.7454/psr.v8i2.1199

2021-08-01

Pharmaceutical Sciences and Research

Abstract:In current medical practice when a patient feels symptoms he/she would consult the doctor. The doctor then gives medication in a one-fits-all fashion. However, recent genetics studies had shown that different genetic makeup can results in different effects on medication, so the medication should be customed for every individual. The main idea of “personalized medicine” is to provide the right intervention including medication to the right patient at the right time and dose. With this approach, the medication paradigm would shift from curative to preventive. The rise of personalized medicine had been possible because the information from ever-increasing biomolecular (proteomics, genomics, and other omics) and health-related data are successfully “mined” by Artificial Intelligence (AI) tools. In this paper, we proposed that AI systems toward personalized medicine must have acceptable performance, be readily interpretable by the clinical community, and be validated in a large cohort. We examined a few landmark papers with the keyword “AI for personalized medicine application”; 1) automatic image-based patient classification, 2) automatic gene-based cancer classification, and 3) automatic health-record heart failure with preserved ejection fraction patient phenotyping. All the examples are evaluated by their performance, interpretability, and clinical validity. From the analysis, we concluded that AI for personalized medicine could benefit by five factors: (1) standardization and pooling of genetics and health data, nationally and internationally, (2) the use of multi-modalities data, (3) disease specialist to guide the development of AI model, (4) investigation of AI-finding by clinical community, and (5) follow-up of AI-finding by the large clinical trial.
Machine learning and artificial intelligence: applications in healthcare epidemiology

Alisa J. Hamilton,Alexandra T. Strauss,Diego A. Martinez,Jeremiah S. Hinson,Scott Levin,Gary Lin,Eili Y. Klein

DOI: https://doi.org/10.1017/ash.2021.192

2021-01-01

Abstract:Abstract Artificial intelligence (AI) refers to the performance of tasks by machines ordinarily associated with human intelligence. Machine learning (ML) is a subtype of AI; it refers to the ability of computers to draw conclusions (ie, learn) from data without being directly programmed. ML builds from traditional statistical methods and has drawn significant interest in healthcare epidemiology due to its potential for improving disease prediction and patient care. This review provides an overview of ML in healthcare epidemiology and practical examples of ML tools used to support healthcare decision making at 4 stages of hospital-based care: triage, diagnosis, treatment, and discharge. Examples include model-building efforts to assist emergency department triage, predicting time before septic shock onset, detecting community-acquired pneumonia, and classifying COVID-19 disposition risk level. Increasing availability and quality of electronic health record (EHR) data as well as computing power provides opportunities for ML to increase patient safety, improve the efficiency of clinical management, and reduce healthcare costs.
Clinical Applications of Machine Learning

Nadayca Mateussi,Michael P. Rogers,Emily A. Grimsley,Meagan Read,Rajavi Parikh,Ricardo Pietrobon,Paul C. Kuo

DOI: https://doi.org/10.1097/as9.0000000000000423

2024-04-18

Annals of Surgery Open

Abstract:Objective: This review introduces interpretable predictive machine learning approaches, natural language processing, image recognition, and reinforcement learning methodologies to familiarize end users. Background: As machine learning, artificial intelligence, and generative artificial intelligence become increasingly utilized in clinical medicine, it is imperative that end users understand the underlying methodologies. Methods: This review describes publicly available datasets that can be used with interpretable predictive approaches, natural language processing, image recognition, and reinforcement learning models, outlines result interpretation, and provides references for in-depth information about each analytical framework. Results: This review introduces interpretable predictive machine learning models, natural language processing, image recognition, and reinforcement learning methodologies. Conclusions: Interpretable predictive machine learning models, natural language processing, image recognition, and reinforcement learning are core machine learning methodologies that underlie many of the artificial intelligence methodologies that will drive the future of clinical medicine and surgery. End users must be well versed in the strengths and weaknesses of these tools as they are applied to patient care now and in the future.
Artificial Intelligence in Medicine: Today and Tomorrow

Giovanni Briganti,Olivier Le Moine

DOI: https://doi.org/10.3389/fmed.2020.00027

IF: 3.9

2020-02-05

Frontiers in Medicine

Abstract:Artificial intelligence-powered medical technologies are rapidly evolving into applicable solutions for clinical practice. Deep learning algorithms can deal with increasing amounts of data provided by wearables, smartphones, and other mobile monitoring sensors in different areas of medicine. Currently, only very specific settings in clinical practice benefit from the application of artificial intelligence, such as the detection of atrial fibrillation, epilepsy seizures, and hypoglycemia, or the diagnosis of disease based on histopathological examination or medical imaging. The implementation of augmented medicine is long-awaited by patients because it allows for a greater autonomy and a more personalized treatment, however, it is met with resistance from physicians which were not prepared for such an evolution of clinical practice. This phenomenon also creates the need to validate these modern tools with traditional clinical trials, debate the educational upgrade of the medical curriculum in light of digital medicine as well as ethical consideration of the ongoing connected monitoring. The aim of this paper is to discuss recent scientific literature and provide a perspective on the benefits, future opportunities and risks of established artificial intelligence applications in clinical practice on physicians, healthcare institutions, medical education, and bioethics.

medicine, general & internal
Artificial Intelligence with Multi-Functional Machine Learning Platform Development for Better Healthcare and Precision Medicine.

Zeeshan Ahmed,Khalid Mohamed,Saman Zeeshan,Xinqi Dong

DOI: https://doi.org/10.1093/database/baaa010

2020-01-01

Database

Abstract:Precision medicine is one of the recent and powerful developments in medical care, which has the potential to improve the traditional symptom-driven practice of medicine, allowing earlier interventions using advanced diagnostics and tailoring better and economically personalized treatments. Identifying the best pathway to personalized and population medicine involves the ability to analyze comprehensive patient information together with broader aspects to monitor and distinguish between sick and relatively healthy people, which will lead to a better understanding of biological indicators that can signal shifts in health. While the complexities of disease at the individual level have made it difficult to utilize healthcare information in clinical decision-making, some of the existing constraints have been greatly minimized by technological advancements. To implement effective precision medicine with enhanced ability to positively impact patient outcomes and provide real-time decision support, it is important to harness the power of electronic health records by integrating disparate data sources and discovering patient-specific patterns of disease progression. Useful analytic tools, technologies, databases, and approaches are required to augment networking and interoperability of clinical, laboratory and public health systems, as well as addressing ethical and social issues related to the privacy and protection of healthcare data with effective balance. Developing multifunctional machine learning platforms for clinical data extraction, aggregation, management and analysis can support clinicians by efficiently stratifying subjects to understand specific scenarios and optimize decision-making. Implementation of artificial intelligence in healthcare is a compelling vision that has the potential in leading to the significant improvements for achieving the goals of providing real-time, better personalized and population medicine at lower costs. In this study, we focused on analyzing and discussing various published artificial intelligence and machine learning solutions, approaches and perspectives, aiming to advance academic solutions in paving the way for a new data-centric era of discovery in healthcare.
Unlocking new potential of clinical diagnosis with artificial intelligence: Finding new patterns of clinical and lab data

Pradeep Kumar Dabla

DOI: https://doi.org/10.4239/wjd.v15.i3.308

2024-03-15

World Journal of Diabetes

Abstract:Recent advancements in science and technology, coupled with the proliferation of data, have also urged laboratory medicine to integrate with the era of artificial intelligence (AI) and machine learning (ML). In the current practices of evidence-based medicine, the laboratory tests analysing disease patterns through the association rule mining (ARM) have emerged as a modern tool for the risk assessment and the disease stratification, with the potential to reduce cardio-vascular disease (CVD) mortality. CVDs are the well recognised leading global cause of mortality with the higher fatality rates in the Indian population due to associated factors like hypertension, diabetes, and lifestyle choices. AI-driven algorithms have offered deep insights in this field while addressing various challenges such as healthcare systems grappling with the physician shortages. Personalized medicine, well driven by the big data necessitates the integration of ML techniques and high-quality electronic health records to direct the meaningful outcome. These technological advancements enhance the computational analyses for both research and clinical practice. ARM plays a pivotal role by uncovering meaningful relationships within databases, aiding in patient survival prediction and risk factor identification. AI potential in laboratory medicine is vast and it must be cautiously integrated while considering potential ethical, legal, and pri-vacy concerns. Thus, an AI ethics framework is essential to guide its responsible use. Aligning AI algorithms with existing lab practices, promoting education among healthcare professionals, and fostering careful integration into clinical settings are imperative for harnessing the benefits of this transformative technology.

endocrinology & metabolism
Explorative study on potential of machine learning and artificial intelligence for improved healthcare diagnosis and treatment

Prakash Date,Varsha Pimprale,Sakshi Mandke

DOI: https://doi.org/10.32629/jai.v7i3.1084

2023-12-26

Journal of Autonomous Intelligence

Abstract:Machine learning (ML) and Artificial intelligence (AI) have demonstrated substantial promise for enhancing healthcare diagnostics and therapy. This study compares the benefits, drawbacks, and uses of these tools to examine their potential in healthcare. ML systems can find trends, increase diagnosis precision, and support professional judgment. Their efficacy may be constrained, though, by bad data quality, a lack of interpretability, and execution issues. On the other hand, AI can support clinical judgment, enhance patient results, and boost healthcare productivity. However, difficulties in implementing them can arise due to restricted generalizability, data protection issues, and legal conformance. To ensure the effective application and acceptance of these technologies in healthcare, it is essential to understand these benefits and constraints. Healthcare providers of the future will be able to make wiser choices regarding patient assessment and therapy options using AL and ML, resulting in an overall enhancement of healthcare services.
More on: mild hemophilia A and inhibitor development

Martin Koestenberger,B. Leschnik,Wolfgang Muntean

DOI: https://doi.org/10.1111/j.1538-7836.2004.00677.x

2004-04-01

Journal of Thrombosis and Haemostasis

Abstract:We read with interest the article by Sharathkumar et al. [1] describing inhibitor development in mild hemophilia A. In this article one of our patients is cited as developing an inhibitor after continuous infusion of factor (F) VIII [2]. We have to mention that this patient, unfortunately not stated clearly in our article, suffers from severe and not from mild hemophilia A. However, we did observe two mildly hemophilic patients who exactly fit in the pattern described by Sharathkumar et al. [1]. In 7and 15-year-old mild hemophiliacs with FVIII plasma levels of 14% and 18%, respectively, surgery due to Perthes disease and severe fracture of the ankle joint, respectively, became necessary. The first patient had been treated before with recombinant factor VIII (rFVIII) only four times since detection of mild hemophilia A while the second was previously untreated. Before surgery inhibitor screening was negative. During surgery and over the following 8 days the first patient received continuous rFVIII in a dose of 4 U kg h followed by 2 U kg h for an additional 3 days. The second patient received rFVIII during surgery and the following 9 days in a dose of 5 U kg h followed by 2 U kg h for an additional 6 days. Good recovery and satisfactory plasma levels were found. Six and 4 weeks later, respectively, the patients were admitted to hospital due to a soft tissue bleeding episode and a right elbow hemarthrosis. FVIII plasma levels were below 1 % and inhibitor test revealed a low titer inhibitor (4 BU) for the first patient, as demonstrated more frequently in this group of patients [3], and a high titer inhibitor (33 BU) for the second patient. No family history of inhibitor development, suggested to be a risk factor [4], was found in our patients. The first patient could be successfully treated with high FVIII concentrations while the second had to be treated with rFVIIa. Immune tolerance induction using a modified Bonn protocol [5] resulted in complete inhibitor suppression within 5 months in the first patient, but in the second patient repeated rFVIIa administrations were necessary due to recurrent hemorrhages during immune tolerance induction. Inhibitor suppression could finally be achieved after 15 months of treatment. As most of the patients by Sharathkumar et al. [1], our patients had multiple risk factors for developing an inhibitor. The inhibitor development occurred within the first few administrations of FVIII, known to be at higher risk for inhibitor development [6]. Our patients also had major surgery, suggested to be a situation that facilitates an antibody response against exogenous FVIII [7], and they had massive continuous infusion of FVIII. Therefore it is impossible to determine what was the reason for inhibitor development, but our cases, similar to the cases reported by Sharathkumar et al. [1], suggest that mild hemophiliacs do have a distinct risk for inhibitor development and should be closely monitored especially in situations with large FVIII exposure.
Artificial Intelligence in Cardiology: Present and Future

Francisco Lopez-Jimenez,Zachi Attia,Adelaide M Arruda-Olson,Rickey Carter,Panithaya Chareonthaitawee,Hayan Jouni,Suraj Kapa,Amir Lerman,Christina Luong,Jose R Medina-Inojosa,Peter A Noseworthy,Patricia A Pellikka,Margaret M Redfield,Veronique L Roger,Gurpreet S Sandhu,Conor Senecal,Paul A Friedman

DOI: https://doi.org/10.1016/j.mayocp.2020.01.038

Abstract:Artificial intelligence (AI) is a nontechnical, popular term that refers to machine learning of various types but most often to deep neural networks. Cardiology is at the forefront of AI in medicine. For this review, we searched PubMed and MEDLINE databases with no date restriction using search terms related to AI and cardiology. Articles were selected for inclusion on the basis of relevance. We highlight the major achievements in recent years in nearly all areas of cardiology and underscore the mounting evidence suggesting how AI will take center stage in the field. Artificial intelligence requires a close collaboration among computer scientists, clinical investigators, clinicians, and other users in order to identify the most relevant problems to be solved. Best practices in the generation and implementation of AI include the selection of ideal data sources, taking into account common challenges during the interpretation, validation, and generalizability of findings, and addressing safety and ethical concerns before final implementation. The future of AI in cardiology and in medicine in general is bright as the collaboration between investigators and clinicians continues to excel.
Statistical dynamical direct methods. II. The three-phase structure invariant.

F. Chukhovskiǐ,J. J. Hu,Laurence Marks

DOI: https://doi.org/10.1107/S0108767300015786

2001-05-01

Acta Crystallographica Section A Foundations of Crystallography

Abstract:The triplet distribution used for kinematical diffraction is extended to the complex case appropriate for dynamical transmission electron diffraction. It is demonstrated that this gives good results if the distributions are handled statistically rather than relying upon single triplet relationships. As a consequence, conventional statistical direct methods will yield a reasonable approximation to the effective dynamical potential for thicknesses when kinematical theory is not appropriate. The recovered effective dynamical potential may be similar to the kinematical potential, but does not have to be and in general will not be.
Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effectiveness

Sebastian Vollmer,Bilal A Mateen,Gergo Bohner,Franz J Király,Rayid Ghani,Pall Jonsson,Sarah Cumbers,Adrian Jonas,Katherine S L McAllister,Puja Myles,David Granger,Mark Birse,Richard Branson,Karel G M Moons,Gary S Collins,John P A Ioannidis,Chris Holmes,Harry Hemingway,David Grainger

DOI: https://doi.org/10.1136/bmj.l6927

2020-03-20

BMJ

Abstract:Machine learning (ML), artificial intelligence (AI), and other modern statistical methods are providing new opportunities to operationalise previously untapped and rapidly growing sources of data for patient benefit. The potential uses include improving diagnostic accuracy,1 more reliably predicting prognosis,2 targeting treatments,3 and increasing the operational efficiency of health systems.4 Examples of potentially disruptive technology with early promise include image based diagnostic applications of ML/AI, which have shown the most early clinical promise (eg, deep learning based algorithms improving accuracy in diagnosing retinal pathology compared with that of specialist physicians5), or natural language processing used as a tool to extract information from structured and unstructured (that is, free) text embedded in electronic health records.2 Although we are only just beginning to understand the wealth of opportunities afforded by these methods, there is growing concern in the academic community that because the products of these methods are not perceived in the same...
Exploring Artificial Intelligence (AI) Technologies in Predictive Medicine: A Systematic Review

Salman O. Isiaka,Ronke S. Babatunde,Rafiu M. Isiaka

DOI: https://doi.org/10.47514/kjcs/2024.1.2.0014

2024-06-30

Abstract:Artificial Intelligence (AI) technologies, including cognitive computing, machine learning (ML), and deep learning (DL), have the potential to transform healthcare. They enhance patient care, improve symptom differentiation, address medication adherence issues, and facilitate continuous patient support. AI's promise in electronic health records (EHRs) includes extracting valuable insights and improving healthcare infrastructure through advanced disease detection and diagnostics. This study reviews and analyzes AI applications in predictive medicine, focusing on emerging pattern recognition techniques and prediction model algorithms. The goal is to assess the current state of AI applications, identify gaps, and develop models that tackle challenges and ethical dilemmas in predictive medicine. A systematic review was conducted using five major scientific literature databases (ScienceDirect, PubMed, Scopus, IEEE Xplore, and Web of Science). The review covered publications from 2015 to May 2024, employing comprehensive search strings to identify relevant studies. Articles were filtered using inclusion and exclusion criteria, and data were extracted and classified based on AI algorithms, application contexts, and key results. Performance metrics of various AI models and techniques were analyzed following PRISMA guidelines. The review found that deep learning models, particularly Convolutional Neural Networks (CNNs) and Gradient Boosting Machines (GBMs), performed best in personalized medicine. Recurrent Neural Networks (RNNs) and Random Forests (RFs) excelled in disease prediction. Machine learning algorithms, feature selection techniques, data fusion methods, and natural language processing (NLP) techniques improved hospital discharge decision-making. Data fusion methods achieved the highest performance metrics, though challenges such as model interpretability and data complexity were identified.
Artificial Intelligence, Machine Learning, and Deep Learning in Health Care

Harsh Kailash Rathi,Pratibha Dawande,Shriram Kane,Amol Gaikwad

DOI: https://doi.org/10.1149/10701.15981ecst

2022-04-24

ECS Transactions

Abstract:Artificial Intelligence (AI) and related technologies are widely used in business and community, and are integrated into health care. This technology has the potential to transform many aspects of patient care, as well as management functions within providers, payers, and pharmaceutical companies. A growing number of research shows that artificial intelligence (AI) can work better or better than humans in important health care tasks such as diagnostics. As machine learning (ML) models become more common in our daily lives, concerns about their potential for injury are growing. In medicine, optimism in the human-health function of ML is influenced by ethical concerns about the potential of tools to magnify existing health disparities. Recent research, for example, has found that when applied to women, minority races, and ethnic groups, as well as those with social insurance, modern clinical prediction algorithms do well. When popular language language models are trained in science textbooks, they complete the templates of clinical notes to compliment hospitals for violent white fathers, according to other studies. Conclusion: While in-depth learning as a means of analysis and modeling has some advantages at the moment, it also highlights a major trend: the integration of health sciences with data. Obstacles to access to health care will be higher than many other industries, where billions of people use in-depth learning and other forms of electronic learning software every day.
Artificial Intelligence in Health Sector: Current Status and Future Perspectives

Phani Teja Nallamothu,Kimberly Morton Cuthrell

DOI: https://doi.org/10.9734/ajrcos/2023/v15i4325

2023-04-15

Asian Journal of Research in Computer Science

Abstract:The developing fields of artificial intelligence (AI)/ machine learning (ML) offer a significant potential to improve healthcare services. Many areas of clinical practice, scientific research, and healthcare management have included AI/ML techniques. Screening and daily fitness monitoring, diagnostic services in gastroenterology, pathology, and radiology, as well as support for clinical decision-making and palliative care, are the main categories involved. However, there are significant obstacles to the widespread use of AI/ML in healthcare, including higher installation and maintenance costs, potentially harmful medical mistakes, a lack of ethical frameworks for AI, unemployment, and reduced capacity building within the human workforce. Many business initiatives have now been created in the field of healthcare AI/ML innovation. They offer everything from advanced diagnostics to vitals monitoring in their products and services. In short, AI/ML may be extremely important in addressing the difficulties with complexity and the explosion of data in the healthcare system. AI/ML is a component of contemporary healthcare, and its further adoption is contingent on thoroughly addressing pertinent issues.
Utilization of Artificial Intelligence in Disease Prevention: Diagnosis, Treatment, and Implications for the Healthcare Workforce

Shahid Ud Din Wani,Nisar Ahmad Khan,Gaurav Thakur,Surya Prakash Gautam,Mohammad Ali,Prawez Alam,Sultan Alshehri,Faiyaz Shakeel,Mohammed M. Ghoneim

DOI: https://doi.org/10.3390/healthcare10040608

2022-03-24

Health Care

Abstract:Artificial intelligence (AI) has been described as one of the extremely effective and promising scientific tools available to mankind. AI and its associated innovations are becoming more popular in industry and culture, and they are starting to show up in healthcare. Numerous facets of healthcare, as well as regulatory procedures within providers, payers, and pharmaceutical companies, may be transformed by these innovations. As a result, the purpose of this review is to identify the potential machine learning applications in the field of infectious diseases and the general healthcare system. The literature on this topic was extracted from various databases, such as Google, Google Scholar, Pubmed, Scopus, and Web of Science. The articles having important information were selected for this review. The most challenging task for AI in such healthcare sectors is to sustain its adoption in daily clinical practice, regardless of whether the programs are scalable enough to be useful. Based on the summarized data, it has been concluded that AI can assist healthcare staff in expanding their knowledge, allowing them to spend more time providing direct patient care and reducing weariness. Overall, we might conclude that the future of “conventional medicine” is closer than we realize, with patients seeing a computer first and subsequently a doctor.

health care sciences & services,health policy & services

[On the fine structure of sieve tube plastids in monocotyls].

AI-Reinforced Wearable Sensors and Intelligent Point-of-Care Tests

Artificial Intelligence in Point-of-Care Biosensing: Challenges and Opportunities

Artificial Intelligence, Physiological Genomics, and Precision Medicine.

Evolving Applications of Artificial Intelligence and Machine Learning in Infectious Diseases Testing

Artificial Intelligence in Medical Diagnosis: Methods, Algorithms and Applications

Artificial Intelligence toward Personalized Medicine

Machine learning and artificial intelligence: applications in healthcare epidemiology

Clinical Applications of Machine Learning

Artificial Intelligence in Medicine: Today and Tomorrow

Artificial Intelligence with Multi-Functional Machine Learning Platform Development for Better Healthcare and Precision Medicine.

Unlocking new potential of clinical diagnosis with artificial intelligence: Finding new patterns of clinical and lab data

Explorative study on potential of machine learning and artificial intelligence for improved healthcare diagnosis and treatment

More on: mild hemophilia A and inhibitor development

Artificial Intelligence in Cardiology: Present and Future

Statistical dynamical direct methods. II. The three-phase structure invariant.

Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effectiveness

Exploring Artificial Intelligence (AI) Technologies in Predictive Medicine: A Systematic Review

Artificial Intelligence, Machine Learning, and Deep Learning in Health Care

Artificial Intelligence in Health Sector: Current Status and Future Perspectives

Utilization of Artificial Intelligence in Disease Prevention: Diagnosis, Treatment, and Implications for the Healthcare Workforce